Prognostic value of follicular dendritic cells in nodular sclerosing Hodgkin's disease

被引:20
作者
Baur, AS
Meugé-Moraw, C
Michel, G
Delacrétaz, F
机构
[1] Univ Lausanne, Inst Pathol, CH-1011 Lausanne, Switzerland
[2] CHUV, Ctr Pluridisciplinaire Oncol, Lausanne, Switzerland
关键词
follicular dendritic cell; Hodgkin's disease; prognostic factors;
D O I
10.1046/j.1365-2559.1998.t01-1-00418.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: In nodular sclerosing Hodgkin's disease (NSHD), the prognostic relevance of the histopathological grading in two subtypes NSI (low-grade) and NSII (high-grade) remains controversial, Analysis of follicular dendritic cells (FDC) may provide new prognostic parameters, Methods and results: Tumours from 59 patients with NSHD were studied, Mean follow-up time was 8 years. Forty-one cases were classified as NSI and 18 as NSII. FDC were immunostained with the paraffin-resistant monoclonal antibodies CD21 and CNA.42. We distinguished three patterns in the neoplastic tissue: FDC1, the presence of well-defined follicle-like structures (n = 20): FDC2, the presence of largely destroyed FDC networks (n = 25); and FDC3, no or a few isolated FDC (n = 14). The three groups differed clearly regarding the frequency of relapse and the survival, The longest survival was seen in the FDC1 group, the shortest in the FDC3 group, the FDC2 group being intermediate (P = 0.0025), FDC status was a discriminating prognostic factor for all patients, and within various age and stage categories. Combining the FDC status and the NSI-NSII grading defined the best survival group as FDC1-NSI. Conclusions: Assessment of FDC pattern, associated with histological subtyping, brings valuable data for predicting survival and outcome in NSHD.
引用
收藏
页码:512 / 520
页数:9
相关论文
共 48 条
[1]   AN IMMUNOHISTOLOGICAL STUDY OF THE CELLULAR-CONSTITUENTS OF HODGKINS-DISEASE USING A MONOCLONAL-ANTIBODY PANEL [J].
ABDULAZIZ, Z ;
MASON, DY ;
STEIN, H ;
GATTER, KC ;
NASH, JRG .
HISTOPATHOLOGY, 1984, 8 (01) :1-25
[2]   FOLLICULAR DENDRITIC CELLS IN HODGKINS-DISEASE [J].
ALAVAIKKO, MJ ;
HANSMANN, ML ;
NEBENDAHL, C ;
PARWARESCH, MR ;
LENNERT, K .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (02) :194-200
[3]   FOLLICULAR DENDRITIC CELLS HAVE PROGNOSTIC RELEVANCE IN HODGKINS-DISEASE [J].
ALAVAIKKO, MJ ;
BLANCO, G ;
AINE, R ;
LEHTINEN, T ;
FELLBAUM, C ;
TASKINEN, PJ ;
SARPOLA, A ;
HANSMANN, ML .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 101 (06) :761-767
[4]   ANALYSIS OF GRADE-1 HODGKINS-DISEASE .6. [J].
BENNETT, MH ;
TU, A ;
HUDSON, GV .
CLINICAL RADIOLOGY, 1981, 32 (05) :491-498
[5]   THE PROGNOSTIC-SIGNIFICANCE OF CELLULAR SUBTYPES IN NODULAR SCLEROSING HODGKINS-DISEASE - AN ANALYSIS OF 271 NON-LAPAROTOMIZED CASES (BNLI REPORT NO 22) [J].
BENNETT, MH ;
MACLENNAN, KA ;
EASTERLING, MJ ;
HUDSON, BV ;
JELLIFFE, AM ;
HUDSON, GV .
CLINICAL RADIOLOGY, 1983, 34 (05) :497-501
[6]  
BOUZOURENE H, 1994, SCHWEIZ MED WOCHENSC, V124, P1726
[7]   RELATIONSHIP OF HISTOLOGICAL SUBTYPES TO PROGNOSIS IN EARLY STAGE HODGKINS-DISEASE - A REVIEW OF 312 CASES IN A CONTROLLED CLINICAL-TRIAL [J].
CULINE, S ;
HENRYAMAR, M ;
DIEBOLD, J ;
AUDEBERT, AA ;
CHOMETTE, G ;
DESAINTMAUR, PP ;
HOERNI, B ;
ROJOUAN, J ;
BERNADOU, A ;
ZITTOUN, R ;
NAJMAN, A .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (03) :551-556
[8]  
DAMORE ESG, 1992, ARCH PATHOL LAB MED, V116, P856
[9]  
DELSOL G, 1993, AM J PATHOL, V142, P1729
[10]   INTERFOLLICULAR HODGKINS-DISEASE [J].
DOGGETT, RS ;
COLBY, TV ;
DORFMAN, RF .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1983, 7 (02) :145-149